Privia Health Group, Inc.
PRVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.64 | -9.80 | -8.90 | 6.07 |
| FCF Yield | 1.66% | 0.28% | -0.89% | 3.18% |
| EV / EBITDA | 134.87 | 291.29 | 315.23 | 263.15 |
| Quality | ||||
| ROIC | 1.10% | 0.26% | 0.54% | 0.51% |
| Gross Margin | 10.51% | 9.15% | 9.53% | 10.41% |
| Cash Conversion Ratio | 7.58 | 2.42 | -5.70 | 13.94 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.91% | 8.03% | 8.02% | 8.57% |
| Free Cash Flow Growth | 537.23% | 133.13% | -132.17% | 125.61% |
| Safety | ||||
| Net Debt / EBITDA | -22.38 | -46.05 | -65.16 | -68.58 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -10.28 | 74.96 | 71.22 | 59.61 |